On paper, retail labor plans often look sound. They’re crafted using forecasts, historical data, and performance goals designed to keep costs down and productivity up. But for the people who work the floor, ring up customers, stock shelves, and make
CHARM Therapeutics (“CHARM”, “The Company”), announces the appointment of Dr Erkut Bahceci as Chief Medical Officer. Erkut’s appointment follows CHARM’s $80 million Series B financing, co-led by NEA and SR One, to advance its next generation menin inhibitor into clinical
Transformational leader brings more than 25 years of experience in the industrial, aerospace, and defense sectors ALIGN PRECISION Corp., a leading manufacturer of precision components and assemblies for critical applications in the aerospace, defense, semiconductor, and evolving high-tech industries, announced
Brought to you by
To repurpose or use any of the content or material on this and our sister sites, explicit written permission needs to be sought.
